University of California San Francisco

Contact Urticaria.

Gimenez-Arnau AM, Maibach H PMID: 34225901

Cutaneous reactions with enfortumab vedotin: A case series and review of the literature.

Dobry AS, Virgen CA, Hosking AM, Mar N, Doan L, Lee B, Smith J PMID: 34235241

Equity and the JAMA Network.

Fontanarosa PB, Flanagin A, Ayanian JZ, Bonow RO, Bressler NM, Christakis D, Disis ML, Josephson SA, Kibbe MR, Öngür D, Piccirillo JF, Redberg RF, Rivara FP, Shinkai K, Yancy CW PMID: 36218750

Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch.

Fadadu RP, Grimes B, Jewell NP, Vargo J, Young AT, Abuabara K, Balmes JR, Wei ML PMID: 33881450

Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch.

Fadadu RP, Grimes B, Jewell NP, Vargo J, Young AT, Abuabara K, Balmes JR, Wei ML PMID: 33881450

Response To: Feasibility of a Tumor Progression Model in PRKAR1A-inactivated Melanomas.

Cohen JN, Yeh I, Mully TW, LeBoit PE, McCalmont TH PMID: 33859070

Response To: Feasibility of a Tumor Progression Model in PRKAR1A-inactivated Melanomas.

Cohen JN, Yeh I, Mully TW, LeBoit PE, McCalmont TH PMID: 33859070

Response To: Feasibility of a Tumor Progression Model in PRKAR1A-inactivated Melanomas.

Cohen JN, Yeh I, Mully TW, LeBoit PE, McCalmont TH PMID: 33859070

Response To: Feasibility of a Tumor Progression Model in PRKAR1A-inactivated Melanomas.

Cohen JN, Yeh I, Mully TW, LeBoit PE, McCalmont TH PMID: 33859070

Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council

Lawrence F.Eichenfield MD, Ayan Kusari, Allison M.Han, SébastienBarbarot MD, PhD, Mette Deleuran MD, DMSce PeterLio MD, Danielle Marcoux MD, AudreyNosbaum MD, PhD, Jean-FrancoisStalder MD PMID: